Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
about
Helical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancer.Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapyPrognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.Management of a locally advanced rectal cancer in a patient who declined surgery.Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.Is It Possible to Shorten the Duration of Adjuvant Chemotherapy for Locally Advanced Rectal Cancer?Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patientsSelective use of adjuvant chemotherapy for rectal cancer patients with ypN0.Pre- and post-surgery treatments in rectal cancer: a long-term single-centre experience.A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy.The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
P2860
Q33657083-F5FF29CA-B2C7-40D7-AE9C-36A19FAE1914Q34630015-7FE6E306-7B4B-41BA-AE7A-390D6862AADCQ35814400-E5269ED6-0729-4A10-A85C-2F28FC2CDCAEQ36307615-CD4FBB06-7692-4DFF-ABBF-29B8AF6DDA32Q36498946-BA91BC88-45D2-4335-AD07-834F3617248BQ36822151-79F6E82C-D3F5-4700-AE93-38D86DD4965BQ36838083-1AE51C25-4051-4F98-8C59-67A9B056EA6EQ37119089-B8E32745-84A6-4F0B-B201-75BA8A946E2FQ37663255-390D5A7C-BB44-411B-AFB3-D1CA120D4558Q37672022-19FF8697-AE57-4B9C-B97E-4A6D754B40F8Q38272671-6BB5998C-B31C-484E-8134-D7624D80B22CQ38285536-A81C859F-ADED-4E51-843C-7F177AB17904Q50973557-36F58FD5-BCE4-456F-B16F-DE358816958DQ53742592-1EA2E76D-FC3B-4BA9-A93A-82A172B4AE45
P2860
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Recurrence rates and prognosti ...... and total mesorectal excision.
@en
Recurrence rates and prognosti ...... and total mesorectal excision.
@nl
type
label
Recurrence rates and prognosti ...... and total mesorectal excision.
@en
Recurrence rates and prognosti ...... and total mesorectal excision.
@nl
prefLabel
Recurrence rates and prognosti ...... and total mesorectal excision.
@en
Recurrence rates and prognosti ...... and total mesorectal excision.
@nl
P2093
P2860
P1476
Recurrence rates and prognosti ...... and total mesorectal excision.
@en
P2093
Anand Govindarajan
Diane Reidy
Garrett M Nash
Jose G Guillem
Larissa K Temple
Martin R Weiser
Philip B Paty
W Douglas Wong
P2860
P2888
P304
P356
10.1245/S10434-011-1788-Y
P577
2011-05-18T00:00:00Z
P6179
1034114119